Trial intelligence / Profile preview

Olive Oil and Supplements vs Metformin in PCOS

NCT05952349Phase 2Completed

Sponsor
Khyber Medical University
Start
Jul 2023
Primary completion
Dec 2023
Countries
1
01

Overview

Phase 2, randomised, open-label trial (2 arms), sponsored by Khyber Medical University. Primary endpoints: Interleukin 6 at 3 months and Interleukin 8 at 3 months. Started Jul 2023; status: completed.

Beyond the preview

Go deeper on NCT05952349.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05952349.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call